2 patents
Utility
Method for inducing a sustained immune response
23 Aug 22
A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone.
Noreen Griffin, Fengping Shan, Nicholas Plotnikoff
Filed: 11 Jun 20
Utility
Method for Inducing a Sustained Immune Response
11 Mar 21
A method for inducing a sustained immune response in humans or animal patient suffering from human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS, autoimmune disease, cancer, inflammation, and neurodegenerative diseases comprises daily administration to such patients a single oral tablet, rapidly dissolving film, capsule, liquid or cream dose of an Immediate release naltrexone composition comprising between about 0.01 to about 10 mg of naltrexone.
Noreen Griffin, Fengping Shan, Nicholas Plotnikoff
Filed: 11 Jun 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first